Argenica Therapeutics (ASX:AGN)
ASX announcement history & article coverage
Transparent by design.
Announcments by Argenica Therapeutics (ASX:AGN) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
New Mechanism Findings Offer Insights Into Phase 2 Signal
Argenica reports multi-target laboratory findings supporting xaranetide’s neuroprotective mechanism
Notice of Annual General Meeting/Proxy Form
Change of Director's Interest Notice
AGM Date & Closing Date for Director Nominations
Concussion Data Selected for Neurotrauma Congress
Appendix 4G & Corporate Governance Statement
Appendix 4E & Annual Report to 30 June 2026
Argenica Therapeutics reports improved FY2026 results and advances stroke drug development
Notification of cessation of securities - AGN
Investor Presentation - Techknow Conference